Delaware | 26-2940963 | |
(State or other jurisdiction of | (IRS Employer | |
incorporation) | Identification No.) |
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ChromaDex has agreed to develop, commercialize and market licensed products as soon as practicable and is subject to certain milestone events pursuant to a commercialization development plan in accordance with the terms of the Agreement.
The foregoing is a summary of the material terms of the Agreement and does not purport to be complete. You should read the complete Agreement, which shall be attached as an exhibit to ChromaDex Corporation's Quarterly Report on Form 10-Q for the quarter ended April 3, 2010 and, when filed, such Agreement shall be incorporated by reference herein. ChromaDex Corporation will seek confidenti al treatment for certain terms of the Agreement at the time of filing such Quarterly Report.
CHROMADEX CORPORATION | ||||||||
Date: March 29, 2010 | By: | /s/ Thomas C. Varvaro | ||||||
Thomas C. Varvaro | ||||||||
Chief Financial Officer | ||||||||